Nifedipine and Myoclonic Dystonia
Authors: ALICIA DE MEDINA
Journal: Annals of Internal Medicine (1986)

Letters and Corrections1 January 1986Nifedipine and Myoclonic DystoniaALICIA DE MEDINA, M.D., OLIVIA BIASINI, M.D., ALFONSO RIVERA, M.D., ALICIA SAMPERA, M.D.ALICIA DE MEDINA, M.D.Search for more papers by this author, OLIVIA BIASINI, M.D.Search for more papers by this author, ALFONSO RIVERA, M.D.Search for more papers by this author, ALICIA SAMPERA, M.D.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-104-1-125_2 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptTo the editor: Hicks and Abraham (1) have reported a case of myoclonic dystonia associated with verapamil therapy. We report the case of a patient who developed myoclonic dystonia apparently induced by nifedipine, a calcium-ion-influx inhibitor. Although nifedipine has side effects (2), such as headache, flushing, lethargy, dizziness, allergic reactions, hypotension, palpitations, and sometimes anginal pain, they are mainly transient.A 35-year-old man was hospitalized with status asthmaticus. He was receiving oxytriphylline (Choledyl; Parke-Davis, Morris Plains, New Jersey), 600 mg/d, and prednisone, 15 mg/d. Three days after admission, we started him on nifedipine therapy, because some studies have reported that...References1. HICKSABRAHAM CK. Verapamil and myoclonic dystonia [Letter]. Ann Intern Med. 1985;103:154. LinkGoogle Scholar2. REYNOLDS J ed. Martindale: The Extra Pharmacopoeia. 28th ed. London; The Pharmaceutical Press; 1982:1628. Google Scholar3. BERMAN J. Dysomia, dysgeusia, and diltiazem [Letter]. Ann Intern Med. 1985;102:717. LinkGoogle Scholar4. LEVINSONKENNEDY JK. Dysosmia, dysgeusia, and nifedipine [Letter]. Ann Intern Med. 1985;102:135-6. LinkGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: Hospital I.V.S.S. "Dr. Domingo Guzmán Lander" Las Garzas Barcelona Venezeula PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited ByNeurological complications of cardiovascular drugsDrug-induced movement disordersIatrogenic neurologyDrug-induced hyperkinetic movement disorders by nonneuroleptic agentsOther Drug-induced Movement DisordersIntractable Delirium Associated With Ziconotide Successfully Treated With Electroconvulsive TherapyRapid Reversal of Life-Threatening Diltiazem-Induced Tetany With Calcium ChlorideVerapamil for severe hyperkinetic movement disordersExtrapyramidal Symptoms Associated with Calcium-Channel BlockersTemporary symptom worsening caused by manidipine hydrochloride in two patients with Parkinson's diseaseTreatment of Persistent Myoclonic Tardive Dystonia with VerapamilDystonia and reflex sympathetic dystrophy induced by ergotamineProbleme bei der Behandlung mit KalziumantagonistenSide Effects — Overdosage — Contraindications — Drug InteractionsDiltiazem-induced parkinsonismMovement disorders and depression due to flunarizine and cinnarizineThe DystoniasNebenwirkungen — Überdosierung (Vergiftung) — Kontraindikationen — ArzneimittelinteraktionenNifedipine, its action on the cationic concentrations in heart, vessels, skeletal muscle and blood in tissues of normotensive and spontaneously hypertensive rats (SHR)Dystonien 1 January 1986Volume 104, Issue 1Page: 125-125KeywordsAllergy and immunologyDystoniaHeadachesHypotension Issue Published: 1 January 1986 PDF DownloadLoading ...